These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 25892862

  • 1. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA, Skill NJ.
    World J Gastroenterol; 2015 Apr 14; 21(14):4126-35. PubMed ID: 25892862
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice.
    Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmann JV.
    Gastroenterology; 2003 May 14; 124(5):1500-8. PubMed ID: 12730888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
    Huang HC, Wang SS, Lee JY, Chen YC, Lee FY, Lin HC, Chang CC, Lee SD.
    J Gastroenterol Hepatol; 2010 Aug 14; 25(8):1401-9. PubMed ID: 20659230
    [Abstract] [Full Text] [Related]

  • 11. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis.
    Zhao X, Deng B, Xu XY, Yang SJ, Zhang T, Song YJ, Liu XT, Wang YQ, Cai DY.
    World J Gastroenterol; 2013 Sep 28; 19(36):6069-76. PubMed ID: 24106408
    [Abstract] [Full Text] [Related]

  • 12. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
    Peleli M, Zollbrecht C, Montenegro MF, Hezel M, Zhong J, Persson EG, Holmdahl R, Weitzberg E, Lundberg JO, Carlström M.
    Free Radic Biol Med; 2016 Oct 28; 99():472-484. PubMed ID: 27609225
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage.
    Hsieh JS, Wang JY, Lin SR, Lian ST, Chen FM, Hsieh MC, Huang TJ.
    J Surg Res; 2003 Nov 28; 115(1):24-32. PubMed ID: 14572769
    [Abstract] [Full Text] [Related]

  • 14. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension.
    Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ.
    Am J Physiol Gastrointest Liver Physiol; 2002 Nov 28; 283(5):G1074-81. PubMed ID: 12381520
    [Abstract] [Full Text] [Related]

  • 15. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M, Ginés P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW.
    Hepatology; 1996 Oct 28; 24(4):947-51. PubMed ID: 8855203
    [Abstract] [Full Text] [Related]

  • 16. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
    Malyshev E, Tazi KA, Moreau R, Lebrec D.
    J Gastroenterol Hepatol; 2007 Dec 28; 22(12):2195-201. PubMed ID: 18031380
    [Abstract] [Full Text] [Related]

  • 17. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
    Du QH, Han L, Jiang JJ, Xu Y, Li WH, Li PT, Wang XY, Jia X.
    World J Gastroenterol; 2014 Nov 28; 20(44):16674-82. PubMed ID: 25469036
    [Abstract] [Full Text] [Related]

  • 18. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
    Gericke A, Goloborodko E, Sniatecki JJ, Steege A, Wojnowski L, Pfeiffer N.
    Exp Eye Res; 2013 Apr 28; 109():60-6. PubMed ID: 23434456
    [Abstract] [Full Text] [Related]

  • 19. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
    Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, Moreau R, Lebrec D.
    Hepatology; 2007 Dec 28; 46(6):1893-906. PubMed ID: 17918268
    [Abstract] [Full Text] [Related]

  • 20. Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice.
    Biecker E, Sägesser H, Reichen J.
    Eur J Clin Invest; 2004 Apr 28; 34(4):283-9. PubMed ID: 15086360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.